$BMY News Article - Bristol Myers Squibb's TRANSCE
Post# of 115
(Total Views: 194)
Posted On: 05/01/2023 2:25:58 PM
$BMY News Article - Bristol Myers Squibb's TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma Meet Primary Endpoint of Overall Response Rate https://marketwirenews.com/news-releases/bris...04864.html
(0)
(0)Bristol-Myers Squibb Company (BMY) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼